Posted by ABMN Staff on May 2nd, 2024
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 8,510,000 shares, a decline of 5.7% from the March...
More of this article »